Raymond James & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$308M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$188M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$172M |
| 4 |
Public Storage
PSA
|
+$47.9M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$46.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$53.7M |
| 2 |
McDonald's
MCD
|
+$46.3M |
| 3 |
Southern Company
SO
|
+$33.8M |
| 4 |
iShares Currency Hedged MSCI Japan ETF
HEWJ
|
+$26.3M |
| 5 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$24.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Healthcare | 9.23% |
| 3 | Financials | 8.81% |
| 4 | Industrials | 6.85% |
| 5 | Communication Services | 6.16% |
Similar funds
Raymond James & Associates's Q2 2017 Portfolio in Review
As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.
- Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
- Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
- Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
- Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
- Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
- Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
- Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.
Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.